Bepi Drug Offers Hope for Hepatitis B Cure
Global News Today | 2 Min News | The Daily News Now!
- Published
- May 28, 2026
- Duration
- 1:31
- Summary source
- description
- Last updated
- May 29, 2026
Discusses daily.
Summary
A breakthrough drug called bepirovirsen could offer a true “functional cure” for hepatitis B—letting some patients stop treatment without the virus rebounding. Unlike current therapies that just suppress the virus, bepirovirsen attacks its genetic code and the S protein, halting replication and boosting the immune system. Early results show better outcome…
Intelligent Report
Sign in to read teasers, or upgrade to Research Pro to commission intelligent report for this episode. Learn more →
Show notes
A breakthrough drug called bepirovirsen could offer a true “functional cure” for hepatitis B—letting some patients stop treatment without the virus rebounding. Unlike current therapies that just suppress the virus, bepirovirsen attacks its genetic code and the S protein, halting replication and boosting the immune system. Early results show better outcomes for patients with lower S protein levels, and the FDA may decide on approval as early as October. While side effects like injection site pain
Themes
- daily